87 results
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
of the Company's operations on the community and the environment;
page 4 of 13
the desirability of the Company maintaining a reputation for high
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
the Company's business relationships with suppliers, customers and others;
the impact of the Company's operations on the community and the environment
8-K
EX-10.4
pq88fxp0ud6dj
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
424B3
q7u1avbq 7zgej
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
jiv9bqc wm1
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
vmtytse ngmuvqj
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
424B5
o126dfsd5chg2 ly
28 Apr 22
Prospectus supplement for primary offering
8:09am